Published in Curr Probl Cardiol on May 01, 2009
Stereotactic Non-invasive Ablation of Ventricular Tachycardia | NCT03819504
Cardiac magnetic resonance for prediction of arrhythmogenic areas. Trends Cardiovasc Med (2015) 1.39
Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J Am Heart Assoc (2013) 0.84
Results of recent studies in catheter ablation of ventricular tachycardias: in whom to abandon the ICD? Herz (2009) 0.75
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation (2006) 4.98
Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol (2011) 4.12
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59
Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 3.58
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol (2005) 3.46
Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol (2010) 2.75
Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation (2007) 2.50
Catheter ablation of atrial arrhythmias after cardiac transplantation: findings at EP study utility of 3-D mapping and outcomes. J Cardiovasc Electrophysiol (2013) 2.49
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2011) 2.48
Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol (2004) 2.39
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 2.23
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol (2009) 2.20
Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm (2007) 2.01
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98
Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol (2009) 1.98
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Wolff-Parkinson-White ablation after a prior failure: a 7-year multicentre experience. Europace (2010) 1.88
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 1.87
Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective "frosty" trial. Heart Rhythm (2004) 1.86
Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol (2010) 1.84
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 1.80
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79
Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report. J Cardiovasc Electrophysiol (2013) 1.79
Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol (2008) 1.78
Electrocardiographic imaging (ECGI), a novel diagnostic modality used for mapping of focal left ventricular tachycardia in a young athlete. Heart Rhythm (2005) 1.77
Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm (2011) 1.76
Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol (2009) 1.74
Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol (2012) 1.72
Sustained ventricular tachycardia associated with corrective valve surgery. Circulation (2007) 1.67
Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. J Am Coll Cardiol (2013) 1.67
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet (2009) 1.64
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol (2006) 1.63
Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation (2006) 1.63
Biventricular stimulation improves right and left ventricular function after tetralogy of Fallot repair: acute animal and clinical studies. Heart Rhythm (2009) 1.58
Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm (2009) 1.56
Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm (2008) 1.56
Identification of large families in early repolarization syndrome. J Am Coll Cardiol (2013) 1.50
Postmyocarditis ventricular tachycardia in patients with epicardial-only scar: a specific entity requiring a specific approach. J Cardiovasc Electrophysiol (2014) 1.50
Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working Group Workshop, March 1, 2006. Transfusion (2008) 1.49
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. Europace (2009) 1.47
NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol (2002) 1.47
Entrainment mapping for rapid distinction of left and right atrial tachycardias. Heart Rhythm (2006) 1.46
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
A practical criterion for the rapid detection of single-loop and double-loop reentry tachycardias. J Cardiovasc Electrophysiol (2013) 1.45
Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia. Heart Rhythm (2011) 1.44
Relation of high-pass filtered unipolar electrograms to bipolar electrograms during ventricular mapping. Pacing Clin Electrophysiol (2011) 1.39
Mapping of atrial tachycardias after catheter ablation for atrial fibrillation: use of bi-atrial activation patterns to facilitate recognition of origin. Heart Rhythm (2010) 1.39
Visualizing intramyocardial steam formation with a radiofrequency ablation catheter incorporating near-field ultrasound. J Cardiovasc Electrophysiol (2013) 1.38
Electrocardiographic left ventricular scar burden predicts clinical outcomes following infarct-related ventricular tachycardia ablation. Heart Rhythm (2013) 1.38
Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol (2008) 1.37
Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm (2006) 1.35
Electrically unexcitable scar mapping based on pacing threshold for identification of the reentry circuit isthmus: feasibility for guiding ventricular tachycardia ablation. Circulation (2002) 1.30
Coronary artery injury due to catheter ablation in adults: presentations and outcomes. Circulation (2009) 1.29
Ventricular arrhythmias and sudden cardiac death. Lancet (2012) 1.29
Subxiphoid surgical approach for epicardial catheter-based mapping and ablation in patients with prior cardiac surgery or difficult pericardial access. Circulation (2004) 1.28
Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review. Eur Heart J (2012) 1.25
Identification of the ventricular tachycardia isthmus after infarction by pace mapping. Circulation (2004) 1.24
Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J (2006) 1.23
Recognition of far-field electrograms during entrainment mapping of ventricular tachycardia. J Am Coll Cardiol (2003) 1.20
Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol (2011) 1.19
Outcomes of cardiac perforation complicating catheter ablation of ventricular arrhythmias. Circ Arrhythm Electrophysiol (2011) 1.19
Catheter ablation for paroxysmal atrial fibrillation. N Engl J Med (2012) 1.17
Strategies for epicardial mapping and ablation of ventricular tachycardia. J Cardiovasc Electrophysiol (2009) 1.17
CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging (2013) 1.17
Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease. J Cardiovasc Electrophysiol (2004) 1.16
Ablation of ventricular tachycardia in patients with structural heart disease. Pacing Clin Electrophysiol (2008) 1.15
Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia. Europace (2008) 1.14
Risk stratification for sudden cardiac death: a plan for the future. Circulation (2014) 1.14